|
시장보고서
상품코드
2052526
생명과학 BPO 시장 : 서비스 유형별, 최종사용자별, 지역별Life Sciences BPO Market, By Service Type, By End User, By Geography |
||||||
생명과학 BPO 시장은 2026년에 5,257억 7,000만 달러로 추정되며, 2033년까지 1조 2,836억 5,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 13.6%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 5,257억 7,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 13.60% | 2033년 시장 규모 예측: | 1조 2,836억 5,000만 달러 |
생명과학 BPO 시장은 제약, 생명공학, 의료기기 기업 및 기타 헬스케어 산업에 종사하는 기업들에게 제공되는 아웃소싱 서비스로 구성되어 있습니다. 이를 통해 생명과학 기업들은 신약개발, 제품 개발, 상업화 등 핵심 업무에 집중할 수 있게 됩니다. 의약품 관리, 임상 데이터 관리, 메디컬 라이팅 및 출판, 파마코비젼, 메디컬 모니터링, 기타 임상시험 관련 서비스 등의 업무는 전문 BPO 사업자에게 위탁하고 있습니다. 비용 최적화, 고급 인프라와 전문 지식에 대한 접근성, 복잡한 규제 프레임워크, 업무 효율화에 대한 요구 등으로 인해 생명과학 분야의 아웃소싱이 증가하고 있습니다.
시장 역학
세계 생명과학 BPO 시장의 성장은 생명과학 기업의 비용 최적화에 대한 니즈 증가와 BPO 서비스 제공업체가 제공하는 고급 인프라와 전문 지식에 대한 접근성이라는 장점에 힘입어 성장세를 보이고 있습니다. 또한, 의약품 개발 및 승인과 관련된 규제 프레임워크는 수년 동안 매우 복잡해져 왔으며, 그 결과 비핵심 기능의 아웃소싱이 필요하게 되었습니다. 가치 중심의 헬스케어로의 전환을 포함한 헬스케어 산업의 트렌드 변화 또한 생명과학 기업의 전략적 아웃소싱을 통한 업무 효율화를 촉진하고 있습니다. 그러나 데이터 보안에 대한 우려, 중요 기능에 대한 관리 권한 상실, 벤더 관리에 따른 운영상의 어려움 등이 시장 성장을 저해하는 요인으로 작용할 수 있습니다. 개발도상국의 의료비 증가, 바이오시밀러 및 유전체 의약품 개발, BPO 서비스 강화를 위한 AI와 블록체인의 통합은 성장 기회를 가져올 수 있습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음과 같은 매개 변수를 기반으로 세계 생명과학 BPO 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 이 세계 생명과학 BPO 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 생명과학 BPO 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 생명과학 BPO 시장 : 서비스 유형별, 2021-2033년
제5장 세계의 생명과학 BPO 시장 : 최종사용자별, 2021-2033년
제6장 세계의 생명과학 BPO 시장 : 지역별, 2021-2033년
제7장 경쟁 구도
제8장 애널리스트의 제안
제9장 참고문헌 및 조사 방법
KSMLife Sciences Bpo Market is estimated to be valued at USD 525.77 Bn in 2026 and is expected to reach USD 1,283.65 Bn by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 525.77 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 13.60% | 2033 Value Projection: | USD 1,283.65 Bn |
The life sciences BPO market comprises outsourcing services provided to pharmaceutical, biotechnology, medical device companies and others in the healthcare industry. It helps life sciences companies to focus on core activities of drug discovery, product development and commercialization. Services like regulatory affairs management, clinical data management, medical writing and publishing, pharmacovigilance, medical monitoring and other clinical trial related services are outsourced to specialized BPO players. Factors such as cost optimization, access to advanced infrastructure and expertise, complex regulatory frameworks and need to streamline operations has increased outsourcing in the life sciences sector.
Market Dynamics
Global life sciences BPO market growth is driven by rising need for cost-optimization among life sciences companies coupled with benefits of access to advanced infrastructure and expertise delivered by BPO service providers. Moreover, regulatory frameworks for drug development and approval have become highly complex over the years, thus, necessitating outsourcing of non-core functionalities. Changing dynamics of the healthcare industry including shift towards value-based care has also prompted life sciences players to streamline their operations through strategic outsourcing. However, factors such as data security concerns, loss of control over critical functions and operational challenges associated with vendor management can hamper the market growth. Growing healthcare expenditure in developing regions, development of biosimilars & genomic drugs and integration of AI/blockchain to enhance BPO services can offer market growth opportunities.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global life sciences BPO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Cognizant, Accenture, Genpact, EXL services, and Catalent.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global life sciences BPO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global life sciences BPO market.
Market Segmentation
- By Service Type (Revenue, USD Bn, 2021 - 2033)
- Pharmaceutical outsourcing
- Contract manufacturing market
- API
- Finished dose form
- Packaging
- Contract research organizations
- Drug discovery
- Preclinical studies
- Clinical trial studies
- Regulatory services
- Pharmacovigilance
- Contract manufacturing market
- Medical devices outsourcing
- Contract manufacturing market
- Electronic manufacturing services
- Finished goods
- Raw materials/components
- Contract research organizations
- Regulatory consulting services
- Product design and development services
- Product testing services
- Product implementation services
- Product upgrade services
- Product maintenance services
- Contract manufacturing market
- Contract sales & market outsourcing
- Others
- By End User (Revenue, USD Bn, 2021 - 2033)
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations Medical Device Companies
- Academic Institutes & Government Organizations
- By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles
- Accenture, Plc
- Boehringer Ingelheim GmbH
- Cognizant Technology Solutions
- Infosys
- Genpact Limited
- ProMab Biotechnologies, Inc.
- Charles River Laboratories International, Inc.
- Catalent, Inc.
- Covance, Inc.
- Fareva
- ICON, Plc
- DSM
- Health Decisions, Inc.
- IQVIA
- Laboratory Corporation of America Holdings
- Syneos Health, Inc.
- Parexel International Corporation
- PRA Health Sciences
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Service Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Life Sciences BPO Market, By Service Type, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Pharmaceutical outsourcing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Contract manufacturing market
- API
- Finished dose form
- Packaging
- Contract research organizations
- Drug discovery
- Preclinical studies
- Clinical trial studies
- Regulatory services
- Pharmacovigilance
- Medical devices outsourcing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Contract manufacturing market
- Electronic manufacturing services
- Finished goods
- Raw materials/components
- Contract research organizations
- Regulatory consulting services
- Product design and development services
- Product testing services
- Product implementation services
- Product upgrade services
- Product maintenance services
- Contract sales & market outsourcing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Life Sciences BPO Market, By End User, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Pharmaceutical Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Biotechnology Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Contract Research Organizations
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Medical Device Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Academic Institutes & Government Organizations
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Life Sciences BPO Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
7. Competitive Landscape
- Company Profiles
- Accenture, Plc
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boehringer Ingelheim GmbH
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cognizant Technology Solutions
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Infosys
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Genpact Limited
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ProMab Biotechnologies, Inc
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Charles River Laboratories International, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Catalent, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Covance, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Fareva
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ICON, Plc
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- DSM
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Health Decisions, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- IQVIA
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Laboratory Corporation of America Holdings
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Syneos Health, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Parexel International Corporation
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- PRA Health Sciences
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Accenture, Plc
8. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
9. References and Research Methodology
- References
- Research Methodology
- About Us and Sales Contact
